The heterogeneity of health care payers suggests that durable therapies need precision financing targeted to each payer segment

Eric NormanFoCUS, Research Briefs

FoCUS participants have identified four payer segments for precision financing: self-insured employers and related organizations; health insurance plans and managed care organizations; Medicare; and Medicaid. Download FoCUS Research Brief_2018F202-014Share the … Read More

Payers Open to Innovative Financing Mechanisms for High Cost Gene Therapies

Eric NormanFoCUS, Research Briefs

In a broad survey, payers favor performance based milestone contracts and risk pools strategies to absorb the surge of high cost gene therapy products expected to enter the market over … Read More